CEACAM5 and colorectal cancer: As a single marker, CEA performed modestly well when colorectal cancer was the outcome, with AUCs ranging from 0.59 in samples collected prospectively between 3–4 years before diagnosis [31] to 0.63 for samples collected in a screening setting [30].